Ask Warren

J2KBIO

420570 · KOSDAQ · ₩420570 · 제이투케이바이오

₩7,300▼ ₩430 (5.56%)End-of-day · Oct 30, 2026 · End-of-day prices.
Trade
Alert me
SellBuy
AnnualQuarterly

Income statement

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Revenue₩16B₩11B₩8.6B₩8.6B₩8.5B₩7.3B₩6.8B₩6.5B
Cost of sales₩9.7B₩6.7B₩5.1B₩5B₩5.4B₩4.6B₩4.3B₩4B
Gross profit₩5.9B₩4.4B₩3.5B₩3.6B₩3.1B₩2.7B₩2.4B₩2.5B
Operating income₩2.7B₩1.9B₩643M₩1.2B₩696M₩332M₩11M−₩133M
Net income₩1.1B₩1.6B₩1.8B−₩45M₩644M₩239M−₩1.4B−₩2.9B
Net income to shareholders₩2.7B₩1.6B₩715M₩838M₩881M₩239M₩289M−₩250M

Balance sheet

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Total assets₩43B₩41B₩38B₩38B₩36B₩36B₩36B₩36B
Current assets₩24B₩23B₩22B₩21B₩19B₩20B₩20B₩20B
Cash and equivalents₩9.2B₩8.9B₩12B₩8B₩4.3B₩4.6B₩7B₩12B
Total liabilities₩6.8B₩7.1B₩4.3B₩4.6B₩3.7B₩5B₩4.6B₩4.8B
Current liabilities₩5.8B₩6B₩3.1B₩3.4B₩2.5B₩3.8B₩2.5B₩2.8B
Borrowings₩400M₩400M₩400M₩400M₩400M₩400M₩1.3B₩1.2B
Total equity₩37B₩34B₩34B₩33B₩32B₩31B₩31B₩31B
Shareholders' equity₩37B₩34B₩34B₩33B₩32B₩31B₩31B₩31B

Cash flow

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Cash from operations₩3.2B−₩437M₩1.4B₩1.1B₩1.1B−₩1.5B₩1.2B₩3B
Free cash flow₩3.2B−₩437M₩1.4B₩1.1B₩1.1B−₩1.5B₩1.2B₩3B
Dividends paid₩2.9B−₩1.5B₩0₩0₩2.3B−₩1.1B——

Consolidated where available. Amounts in won.

Also known as: J2KBIO / 제이투케이바이오 / 420570 / KRX:420570

Source: KRX statistical information